Novo Nordisk A/S
NONOF
$49.69
$0.170.34%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.45B | 15.30B | 16.18B | 15.05B | 14.65B |
| Total Depreciation and Amortization | 2.17B | 1.98B | 1.77B | 1.43B | 1.20B |
| Total Amortization of Deferred Charges | 49.57M | 36.44M | 36.44M | 36.44M | 36.44M |
| Total Other Non-Cash Items | -389.46M | 1.77B | 1.21B | 3.08B | 1.39B |
| Change in Net Operating Assets | 803.95M | -426.97M | -1.31B | -610.73M | 307.66M |
| Cash from Operations | 18.08B | 18.65B | 17.89B | 18.98B | 17.59B |
| Capital Expenditure | -9.13B | -8.56B | -8.21B | -7.49B | -6.83B |
| Sale of Property, Plant, and Equipment | -- | -142.90K | 4.50K | 4.50K | 4.50K |
| Cash Acquisitions | 156.49M | -11.65B | -11.65B | -11.74B | -11.74B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.22B | 1.65B | 632.10M | -814.90M | 42.96M |
| Cash from Investing | -12.20B | -18.56B | -19.23B | -20.05B | -18.53B |
| Total Debt Issued | 103.93B | 118.07B | 117.48B | 106.75B | 79.39B |
| Total Debt Repaid | -79.19B | -78.47B | -77.85B | -18.05B | -6.34B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.39B | -8.88B | -11.28B | -18.73B | -20.18B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.59B | -7.59B | -7.27B | -7.27B | -6.45B |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 21.45B | 0.00 |
| Cash from Financing | -4.35B | -3.68B | -3.71B | 5.73B | 1.12B |
| Foreign Exchange rate Adjustments | -108.95M | -23.01M | -84.15M | 45.12M | 63.66M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.43B | -3.61B | -5.13B | 4.70B | 241.41M |